BiotinTeam
23 Eki 2024
The BIOTIN Project team kicked off their Istanbul visit with an in-depth tour of Boğaziçi University’s Center for Life Sciences & Technologies (LifeSci), a hub for groundbreaking research in biotechnology and targeted therapy. As this was the introductory event of the project, it also provided a valuable opportunity for fellows and supervisors to meet in person, network, and build collaborative relationships.
The visit included insights into Motion Assistive Devices Ecosystem (MADE in NSTP), neurotechnology solutions, and advanced biomedical research facilities. The LifeSci Center hosts state-of-the-art laboratories dedicated to targeted therapy technologies, molecular biology, biomedical engineering, and neurotechnology research. These facilities offer cutting-edge infrastructure that enables scientists to develop innovative healthcare solutions, aligning closely with BIOTIN’s vision of fostering entrepreneurial biomedical scientists.
Additionally, the visit featured an introduction to the Neurotechnological Solutions Platform (NTSP), a large-scale university-industry collaboration structure designed to co-develop translational innovations in neurorobotics, neuroinformatics, clinical neurotechnology, and neurometaphysics. NTSP is part of the NeurotechEU initiative and includes partners such as Bilkent, Sabancı, and Istanbul Universities, along with industry leaders like Karel Electronics and Interact Technologies. The platform is dedicated to advancing human motion assistive devices and medical imaging technologies, bridging the gap between research and commercialization.
Engaging discussions with experts, including Prof. Cengizhan Öztürk, Prof. Rana Sanyal, and Prof. Can Yücesoy, provided the BIOTIN fellows with a unique opportunity to explore the latest advancements in healthcare and biotech solutions. Prof. Can Yücesoy, who is the Director of NTSP and BOUN Biomechanics Lab, highlighted how NTSP integrates biomechanics, advanced imaging, and AI-driven neurotechnologies to develop next-generation assistive devices.
The visit allowed fellows to gain a deeper understanding of how academic research can translate into real-world biomedical applications, while also inspiring them to think about future entrepreneurial ventures.
For BIOTIN doctoral students, this visit was instrumental in understanding the commercialization potential of biomedical research. By engaging with leading scientists and industry experts, the fellows gained insights into how cutting-edge discoveries can be transformed into market-ready technologies, aligning with their goal of becoming entrepreneurially driven biomedical innovators. The interactions and shared experiences during this visit helped strengthen their sense of community and collaboration, setting a strong foundation for their doctoral journey.
